EP1085902A2
Therapeutic compositions that produce an immune response by altering the antigen
Abstract
This record has no abstract on file.
Term
Term ended
Projected expiry passed 15 June 2019, 7.3 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
10 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| WO0185204A2 | Cites | World Intellectual Property Organization (WIPO) | Examiner |
| WO02076384A2 | Cites | World Intellectual Property Organization (WIPO) | Examiner |
| WO9742973A1 | Cites | World Intellectual Property Organization (WIPO) | Examiner |
106 members in 22 offices
Priority claims5
| Document | Office | Kind | Date |
|---|---|---|---|
| 94598 | United States of America | – | |
| 9459898 | United States of America | A | |
| 152698 | United States of America | – | |
| 15269898 | United States of America | A | |
| 9901114 | International Bureau of the World Intellectual Property Organization (WIPO) | W |
Members106
| Document | Office | Kind | |
|---|---|---|---|
| CA2253602A1 | Canada | A1 | |
| WO9742973A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU5658096A | Australia | A | |
| WO9802762A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU4643997A | Australia | A | |
| WO9802762A3 | World Intellectual Property Organization (WIPO) | A3 | |
| NO20061203L | Norway | L | |
| NO985304D0 | Norway | D0 | |
| NO985304L | Norway | L | |
| CA2292912A1 | Canada | A1 | |
| WO9857661A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU8143998A | Australia | A | |
| EP0908022A2 | European Patent Office (EPO) | A2 | |
| EP0910407A1 | European Patent Office (EPO) | A1 | |
| BR9612619A | Brazil | A | |
| IL126803D0 | Israel | D0 | |
| JPH11509558A | Japan | A | |
| AU711270B2 | Australia | B2 | |
| CN1238868A | China | A | |
| CA2333221A1 | Canada | A1 | |
| WO9965517A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU4159399A | Australia | A | |
| WO9965517A3 | World Intellectual Property Organization (WIPO) | A3 | |
| CA2253058A1 | Canada | A1 | |
| HU9903770A2 | Hungary | A2 | |
| HUP9903770A2 | Hungary | A2 | |
| ZA9810275B | South Africa | B | |
| EP1009433A1 | European Patent Office (EPO) | A1 | |
| US6086873A | United States of America | A | |
| NZ332588A | New Zealand | A | |
| EP1085902A2This record | European Patent Office (EPO) | A2 | |
| AU732505B2 | Australia | B2 | |
| US6241985B1 | United States of America | B1 | |
| HU9903770A3 | Hungary | A3 | |
| HUP9903770A3 | Hungary | A3 | |
| CA2399067A1 | Canada | A1 | |
| WO0159452A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU4098201A | Australia | A | |
| US2001036457A1 | United States of America | A1 | |
| NZ503032A | New Zealand | A | |
| JP2002504154A | Japan | A | |
| KR20020011137A | Republic of Korea | A | |
| IL139832D0 | Israel | D0 | |
| US2002022235A1 | United States of America | A1 | |
| NZ505174A | New Zealand | A | |
| US2002048586A1 | United States of America | A1 | |
| NZ516264A | New Zealand | A | |
| JP2002518342A | Japan | A | |
| WO0159452A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1254374A2 | European Patent Office (EPO) | A2 | |
| EP0910407B1 | European Patent Office (EPO) | B1 | |
| AT233102T | Austria | T | |
| ATE233102T1 | Austria | T1 | |
| EP1297846A1 | European Patent Office (EPO) | A1 | |
| DE69626423D1 | Germany | D1 | |
| CA2464947A1 | Canada | A1 | |
| WO03034977A2 | World Intellectual Property Organization (WIPO) | A2 | |
| DK0910407T3 | Denmark | T3 | |
| AU762699B2 | Australia | B2 | |
| JP2003522774A | Japan | A | |
| PT910407E | Portugal | E | |
| SI0910407T1 | Slovenia | T1 | |
| ES2193240T3 | Spain | T3 | |
| IL126803A | Israel | A | |
| DE69626423T2 | Germany | T2 | |
| NO20042166L | Norway | L | |
| GB0409191D0 | United Kingdom | D0 | |
| WO03034977A3 | World Intellectual Property Organization (WIPO) | A3 | |
| GB2397018A | United Kingdom | A | |
| JP3565351B2 | Japan | B2 | |
| DE10297379T5 | Germany | T5 | |
| EP1009433A4 | European Patent Office (EPO) | A4 | |
| US2005063976A1 | United States of America | A1 | |
| AT500649A1 | Austria | A1 | |
| AU2001240982B2 | Australia | B2 | |
| NO321511B1 | Norway | B1 | |
| GB2397018B | United Kingdom | B | |
| US2006159688A1 | United States of America | A1 | |
| AU2006203074A1 | Australia | A1 | |
| IL139832A | Israel | A | |
| US2007036798A1 | United States of America | A1 | |
| EP1254374B1 | European Patent Office (EPO) | B1 | |
| US2007092522A1 | United States of America | A1 | |
| AT360212T | Austria | T | |
| ATE360212T1 | Austria | T1 | |
| DE60127935D1 | Germany | D1 | |
| PT1254374E | Portugal | E | |
| EP1820514A2 | European Patent Office (EPO) | A2 | |
| EP1821104A2 | European Patent Office (EPO) | A2 | |
| DK1254374T3 | Denmark | T3 | |
| EP1820514A3 | European Patent Office (EPO) | A3 | |
| EP1821104A3 | European Patent Office (EPO) | A3 | |
| ES2284624T3 | Spain | T3 | |
| CH696871A5 | Switzerland | A5 | |
| US7318921B2 | United States of America | B2 | |
| DE60127935T2 | Germany | T2 | |
| AU2002358246B2 | Australia | B2 | |
| US7361346B1 | United States of America | B1 | |
| US2008131443A1 | United States of America | A1 | |
| US2008206318A1 | United States of America | A1 |
Showing 100 of 106
12 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Application withdrawnWithdrawn18W | 18W | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION HAS BEEN WITHDRAWNSTAA | STAA | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | |
| First examination report despatched17Q | 17Q | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | |
| Request for examination filed17P | 17P | |
| Designated contracting statesAK | AK | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI |
Numbers
- Publication
- 1085902
- Application
- 999252158
Titles3
- German
- THERAPEUTISCHER ZUSAMMENSETZUNG DIE EINE IMMUNANTWORT DURCH ÄNDERUNG VOM ANTIGEN ANREGT
- English
- THERAPEUTIC COMPOSITIONS THAT PRODUCE AN IMMUNE RESPONSE BY ALTERING THE ANTIGEN
- French
- COMPOSITIONS THERAPEUTIQUES PRODUISANT UNE REPONSE IMMUNITAIRE PAR RENOUVELLEMENT DES ANTIGENES
Classification
- CPC, 11
- C07K16/4266
- A61K38/00
- A61K39/00
- A61K41/0042
- C07K16/3015
- C07K16/3069
- C07K2317/734
- C07K2317/34
- A61P35/00
- A61P37/02
- A61P37/04
- IPC, 10
- A61K45 00
- A61K38 00
- A61K39 00
- A61K39 395
- A61K41 00
- A61P35 00
- A61P37 02
- A61P37 04
- C07K16 30
- C07K16 42
Designated states19
- Contracting states, 19
- Austria
- Belgium
- Switzerland
- Cyprus
- Germany
- Denmark
- Spain
- Finland
- France
- United Kingdom
- Greece
- Ireland
- Italy
- Liechtenstein
- Luxembourg
- Monaco
- Netherlands (Kingdom of the)
- Portugal
- Sweden